IC
PASG icon

Ikarian Capital’s Passage Bio PASG Stock Holding History

Ikarian Capital’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$486K Buy
99,517
+31,393
+46% +$196K 0.05% 121
2026
Q1 		$535K Buy
+68,124
New +$705K 0.04% 125
2022
Q2 		– Sell
-3,593
Closed -$223K – 185
2022
Q1 		$223K Buy
3,593
+201
+6% +$16.6K 0.03% 161
2021
Q4 		$431K Hold
3,392
– – 0.06% 135
2021
Q3 		$677K Sell
3,392
-3,901
-53% -$930K 0.05% 176
2021
Q2 		$1.93M Hold
7,293
– – 0.16% 133
2021
Q1 		$2.55M Buy
7,293
+458
+7% +$196K 0.09% 186
2020
Q4 		$3.5M Buy
+6,835
New +$2.74M 0.15% 117

Other funds holding PASG

LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
YCM
Yiheng Capital Management San Francisco, California $291M AUM 19.43% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VA
Verdad Advisers Boston, Massachusetts $104M AUM
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Ikarian Capital's PASG Position: Q2 2026 in Review

Ikarian Capital increased its Passage Bio (PASG) stake by 46% in Q2 2026, buying an estimated $196K and bringing the position to 99,517 shares worth $486K. The position accounts for 0.05% of the portfolio, ranked #121.

Ikarian Capital first reported a position in PASG in Q4 2020 and has held it in 8 quarters since. The position peaked at $3.5M in Q4 2020. 29 funds tracked by Wall St. Rank hold PASG as of Q2 2026.

  • Ikarian Capital held 99,517 shares of Passage Bio worth $486K as of Q2 2026.
  • Ikarian Capital bought 31,393 Passage Bio shares in Q2 2026, an estimated $196K.
  • Passage Bio made up 0.05% of Ikarian Capital's portfolio in Q2 2026, its #121 holding.
  • Ikarian Capital first reported a position in Passage Bio in Q4 2020 and has held it in 8 quarters since.
  • Ikarian Capital's Passage Bio position peaked at $3.5M in Q4 2020.
  • 29 funds tracked by Wall St. Rank held Passage Bio as of Q2 2026.

Based on Ikarian Capital's 13F filing for Q2 2026, filed 14 Aug 2026.